APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study
Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.. Archives of neurology, 2004-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Both family aggregation and apolipoprotein E (APOE) epsilon4 allele are well-known risk factors for dementia, but the relation between these two factors remains unclear. Objective To explore whether the risk of dementia and Alzheimer disease (AD) due to a positive family history is explained by APOE genotypes. Design Community-based cohort study. Setting The Kungsholmen district of Stockholm, Sweden. Participants A total of 907 nondemented people 75 years or older, followed up for 6 years to detect incident dementia and AD cases according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Main outcome measures Risk of dementia and AD by Cox proportional hazards models after controlling for several potential confounders. Results Subjects who had at least 2 siblings with dementia were at an increased risk of AD. Individuals with both APOE epsilon4 allele and at least 2 affected first-degree relatives had a higher risk of dementia and AD compared with those without these 2 factors. Similar results were obtained for history of dementia separately in parents or siblings. Among the epsilon4 allele carriers, subjects with 2 or more first-degree demented relatives had increased risk of dementia and AD, whereas no increased risk was detected among non-epsilon4 carriers. Conclusions Family history of dementia was associated with an increased risk of dementia and AD in this very old population, but only among APOE epsilon4 carriers. This suggests the existence of other genetic or environmental risk factors that may be active in the presence of the APOE epsilon4 allele.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 907 participants. In 907 non-demented people aged 75 or older followed for six years, having at least two siblings with dementia was linked to a higher risk of Alzheimer's disease. Among APOE4 carriers, those with two or more affected first-degree relatives had increased risk, while no increased risk was seen in non-carriers, suggesting family history and APOE4 together raise risk.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Huang, W., Qiu, C., von Strauss, E., Winblad, B., & Fratiglioni, L. (2004). APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Archives of neurology. https://doi.org/10.1001/archneur.61.12.1930
Vancouver
Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Archives of neurology. 2004. doi:10.1001/archneur.61.12.1930. PMID: 15596614.
BibTeX
@article{huang2004-15596614,
author = {Huang, W. and Qiu, C. and von Strauss, E. and Winblad, B. and Fratiglioni, L.},
title = {{APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study}},
journal = {Archives of neurology},
year = {2004},
doi = {10.1001/archneur.61.12.1930},
pmid = {15596614},
url = {https://doi.org/10.1001/archneur.61.12.1930}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Subjects who had at least 2 siblings with dementia were at an increased risk of AD.
- Individuals with both APOE epsilon4 allele and at least 2 affected first-degree relatives had a higher risk of dementia and AD compared with those without these 2 factors.
- Similar results were obtained for history of dementia separately in parents or siblings.
- Among the epsilon4 allele carriers, subjects with 2 or more first-degree demented relatives had increased risk of dementia and AD, whereas no increased risk was detected among non-epsilon4 carriers.
- Conclusions Family history of dementia was associated with an increased risk of dementia and AD in this very old population, but only among APOE epsilon4 carriers.
Why it matters
In 907 non-demented people aged 75 or older followed for six years, having at least two siblings with dementia was linked to a higher risk of Alzheimer's disease. Among APOE4 carriers, those with two or more affected first-degree relatives had increased risk, while no increased risk was seen in non-carriers, suggesting family history and APOE4 together raise risk.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcohort study
- Participants907
- Evidence strengthModerate
How this study scored 56/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 54 of the 96 points we could judge it on, which is 56 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2004 — older than 20 years, still counted |
| Sample size | 2 / 4 | 907 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 133 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.5 citations a year over 24 year(s) since 2004 |
| Impact for its field and year | 3 / 6 | Cited 3.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Laura Fratiglioni: h-index 133 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Karolinska Institutet: institution h-index 1,477 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 15596614) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 54 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 54 of the 96 points we could judge it on is 56 out of 100. |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Genetics from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.